Advertisement
Screener

EyePoint, Inc. (EYPT) Increase (Decrease) in Accounts Receivable and Other Operating Assets

2.8 / 5 stars · 68/120 Roast Me

EyePoint, Inc. Increase (Decrease) in Accounts Receivable and Other Operating Assets

EyePoint, Inc. (EYPT) reported Increase (Decrease) in Accounts Receivable and Other Operating Assets of -$14.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets · last filed 2026-08-05

  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2026-06-30 was -$19.25M, a 10792.22% decline year-over-year.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2026-03-31 was $4.95M.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2025-12-31 was $10.78M.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2025-09-30 was $3.13M, a 233.76% increase year-over-year.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for fiscal 2025 was $10.67M, a 4271.72% increase from fiscal 2024.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for fiscal 2024 was $244.00K.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for fiscal 2023 was -$14.43M, a 642.15% decline from fiscal 2022.
  • EyePoint, Inc. increase (decrease) in accounts receivable and other operating assets for fiscal 2022 was $2.66M, a 74.89% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable and Other Operating Assets 3 monthIncrease (Decrease) in Accounts Receivable and Other Operating Assets 6 monthIncrease (Decrease) in Accounts Receivable and Other Operating Assets 9 monthIncrease (Decrease) in Accounts Receivable and Other Operating Assets 12 month
2026-06-30-$19.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$14.29M
10-Q · filed 2026-08-05
-$3.51M
derived: sum of 3 quarters · filed 2026-08-05
-$377.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$4.95M
10-Q · filed 2026-05-07
$15.73M
derived: sum of 2 quarters · filed 2026-05-07
$18.87M
derived: sum of 3 quarters · filed 2026-05-07
$19.05M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$10.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$13.91M
derived: sum of 2 quarters · filed 2026-03-05
$14.10M
derived: sum of 3 quarters · filed 2026-08-05
$10.67M
10-K · filed 2026-03-05
2025-09-30$3.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$3.31M
derived: sum of 2 quarters · filed 2026-08-05
-$114.00K
10-Q · filed 2025-11-06
-$1.98M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$180.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$3.25M
10-Q · filed 2026-08-05
-$5.11M
derived: sum of 3 quarters · filed 2026-08-05
-$4.17M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$3.43M
10-Q · filed 2026-05-07
-$5.29M
derived: sum of 2 quarters · filed 2026-05-07
-$4.35M
derived: sum of 3 quarters · filed 2026-05-07
-$7.44M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$1.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$924.00K
derived: sum of 2 quarters · filed 2026-03-05
-$4.02M
derived: sum of 3 quarters · filed 2026-03-05
$244.00K
10-K · filed 2026-03-05
2024-09-30$939.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$2.15M
derived: sum of 2 quarters · filed 2025-11-06
$2.11M
10-Q · filed 2025-11-06
$2.38M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$3.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$1.17M
10-Q · filed 2025-08-07
$1.44M
derived: sum of 3 quarters · filed 2025-08-07
-$9.31M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$4.26M
10-Q · filed 2025-05-08
$4.53M
derived: sum of 2 quarters · filed 2025-05-08
-$6.22M
derived: sum of 3 quarters · filed 2025-05-08
-$5.24M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$269.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
-$10.48M
derived: sum of 2 quarters · filed 2025-03-06
-$9.50M
derived: sum of 3 quarters · filed 2025-03-06
-$14.43M
10-K · filed 2025-03-06
2023-09-30-$10.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$9.77M
derived: sum of 2 quarters · filed 2024-11-07
-$14.70M
10-Q · filed 2024-11-07
-$20.98M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$979.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$3.95M
10-Q · filed 2024-08-08
-$10.23M
derived: sum of 3 quarters · filed 2024-08-08
-$10.60M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$4.93M
10-Q · filed 2024-05-09
-$11.21M
derived: sum of 2 quarters · filed 2024-05-09
-$11.58M
derived: sum of 3 quarters · filed 2024-05-09
-$5.21M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$6.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$6.65M
derived: sum of 2 quarters · filed 2024-03-08
-$275.00K
derived: sum of 3 quarters · filed 2024-03-08
$2.66M
10-K · filed 2024-03-08
2022-09-30-$368.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$6.00M
derived: sum of 2 quarters · filed 2023-11-03
$8.94M
10-Q · filed 2023-11-03
$14.92M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$6.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$9.31M
10-Q · filed 2023-08-04
$15.29M
derived: sum of 3 quarters · filed 2023-08-04
$13.97M
derived: sum of 4 quarters · filed 2023-08-04
2022-03-31$2.94M
10-Q · filed 2023-05-04
$8.92M
derived: sum of 2 quarters · filed 2023-05-04
$7.60M
derived: sum of 3 quarters · filed 2023-05-04
$11.22M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$5.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$4.66M
derived: sum of 2 quarters · filed 2023-03-10
$8.29M
derived: sum of 3 quarters · filed 2023-03-10
$10.60M
10-K · filed 2023-03-10
2021-09-30-$1.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$2.31M
derived: sum of 2 quarters · filed 2022-11-04
$4.62M
10-Q · filed 2022-11-04
$2.27M
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30$3.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$5.94M
10-Q · filed 2022-08-05
$3.59M
derived: sum of 3 quarters · filed 2022-08-05
$5.57M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$2.32M
10-Q · filed 2022-05-06
-$35.00K
derived: sum of 2 quarters · filed 2022-05-06
$1.94M
derived: sum of 3 quarters · filed 2022-05-06
-$4.85M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31-$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
-$374.00K
derived: sum of 2 quarters · filed 2022-03-14
-$7.17M
derived: sum of 3 quarters · filed 2022-03-14
-$4.85M
10-K · filed 2022-03-14
2020-09-30$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$4.81M
derived: sum of 2 quarters · filed 2021-11-05
-$2.49M
10-Q · filed 2021-11-05
$2.13M
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30-$6.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$4.47M
10-Q · filed 2021-08-06
$151.00K
derived: sum of 3 quarters · filed 2021-08-06
$151.00K
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31$2.32M
10-Q · filed 2021-05-05
$6.94M
derived: sum of 2 quarters · filed 2021-05-05
$6.94M
derived: sum of 3 quarters · filed 2021-05-05
$15.58M
derived: sum of 4 quarters · filed 2021-05-05
2019-12-31$4.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$4.62M
derived: sum of 2 quarters · filed 2021-03-12
$13.26M
derived: sum of 3 quarters · filed 2021-03-12
$15.30M
10-K · filed 2021-03-12
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$8.63M
derived: sum of 2 quarters · filed 2020-11-06
$10.68M
10-Q · filed 2020-11-06
$10.86M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$8.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$10.68M
10-Q · filed 2020-08-05
$10.86M
derived: sum of 3 quarters · filed 2020-08-05
$11.39M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$2.05M
10-Q · filed 2020-05-08
$2.23M
derived: sum of 2 quarters · filed 2020-05-08
$2.76M
derived: sum of 3 quarters · filed 2020-05-08
$2.75M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$182.00K
derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-16
$711.00K
10-K · filed 2020-03-16
$703.00K
derived: sum of 3 quarters · filed 2020-03-16
$952.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-09-30$529.00K
10-Q · filed 2018-11-09
$521.00K
derived: sum of 2 quarters · filed 2019-08-07
$770.00K
10-Q · filed 2019-11-07
$825.00K
derived: sum of 4 quarters · filed 2019-08-07
2018-06-30-$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$241.00K
10-Q · filed 2019-08-07
$296.00K
derived: sum of 3 quarters · filed 2019-08-07
$167.00K
10-K · filed 2020-03-16
2018-03-31$249.00K
10-Q · filed 2019-05-10
$304.00K
derived: sum of 2 quarters · filed 2019-05-10
$175.00K
10-Q · filed 2018-05-10
-$76.00K
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$55.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
-$74.00K
10-Q · filed 2018-02-08
-$325.00K
derived: sum of 3 quarters · filed 2020-03-16
-$238.00K
derived: sum of 4 quarters · filed 2020-03-16
2017-09-30-$129.00K
10-Q · filed 2018-11-09
-$380.00K
derived: sum of 2 quarters · filed 2020-03-16
-$293.00K
derived: sum of 3 quarters · filed 2020-03-16
-$241.00K
derived: sum of 4 quarters · filed 2020-03-16
2017-06-30-$251.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$164.00K
derived: sum of 2 quarters · filed 2020-03-16
-$112.00K
derived: sum of 3 quarters · filed 2020-03-16
-$120.00K
10-K · filed 2020-03-16
2017-03-31$87.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10
$139.00K
derived: sum of 2 quarters · filed 2018-05-10
$131.00K
10-Q · filed 2018-05-10
2016-12-31$52.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
$44.00K
10-Q · filed 2018-02-08
2016-09-30-$8.00K
10-Q · filed 2017-11-08
2016-03-31$236.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08
-$148.00K
derived: sum of 2 quarters · filed 2017-05-08
-$284.00K
10-Q · filed 2017-05-08
2015-12-31-$384.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09
-$520.00K
10-Q · filed 2017-02-09
2015-09-30-$136.00K
10-Q · filed 2016-11-08
2015-03-31-$230.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-06
-$24.93M
derived: sum of 2 quarters · filed 2016-05-06
$388.00K
10-Q · filed 2016-05-06
2014-12-31-$24.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09
$618.00K
10-Q · filed 2016-02-09
2014-09-30$25.32M
10-Q · filed 2015-11-06
2014-03-31-$319.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08
-$1.47M
derived: sum of 2 quarters · filed 2015-05-08
-$1.02M
10-Q · filed 2015-05-08
2013-12-31-$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06
-$697.00K
10-Q · filed 2015-02-06
2013-09-30$457.00K
10-Q · filed 2014-11-07
2013-03-31$432.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
$269.00K
derived: sum of 2 quarters · filed 2014-05-14
$122.00K
10-Q · filed 2014-05-14
2012-12-31-$163.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12
-$310.00K
10-Q · filed 2014-02-12
2012-09-30-$147.00K
10-Q · filed 2013-11-13
2012-03-31$250.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14
$418.00K
derived: sum of 2 quarters · filed 2013-05-14
$212.00K
10-Q · filed 2013-05-14
2011-12-31$168.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08
-$38.00K
10-Q · filed 2013-02-08
2011-09-30-$206.00K
10-Q · filed 2012-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15